|
|
"A comprehensive, collaborative elections resource."
|
Rules on Bioengineered Animals
|
|---|
| Parent(s) |
Issue
|
| Contributor | ArmyDem |
| Last Edited | ArmyDem Sep 18, 2008 06:11pm |
| Logged |
0
|
| Category | News |
| Media | Newspaper - Washington Post |
| News Date | Friday, September 19, 2008 12:00:00 AM UTC0:0 |
| Description | FDA to Release Guidelines for Stages of Genetic Modification
By David Brown
Washington Post Staff Writer
Thursday, September 18, 2008; Page A02
The Food and Drug Administration will release today long-awaited regulatory guidelines governing genetic engineering of animals for food, drugs or medical devices.
Although none of the provisions is likely to surprise the biotech industry, their formal appearance after years of discussion is expected to energize a field whose commercial potential is huge but so far unrealized.
The agency's regulatory control of animals will be considerably stronger than its oversight of genetically engineered plants and microorganisms. The latter -- or substances derived from them -- are on the market and, in some cases, have proved controversial.
The guidelines tell companies what the FDA wants to know about their work at virtually every stage of creating an engineered animal.
For example, biotech firms will be asked to provide the molecular identity of snippets of DNA inserted in an animal's genome, as well as where the genetic message lands and whether it descends unaltered through subsequent generations. The FDA also wants to be told how the genetic alterations might change an animal's health, behavior and nutritional value. |
| Share |
|
|
2¢
|
|
| Article | Read Full Article |
|
| Date |
Category |
Headline |
Article |
Contributor |
|
|
